期刊文献+

一种高效表达小干扰RNA载体的构建研究 被引量:2

Construction of an expression vector for high expression of siRNA
下载PDF
导出
摘要 目的:用mir30前体骨架来构建高效表达小干扰RNA载体。方法:通过基因合成的方法,将mir30前体骨架进行全长基因合成,并在合成的mir30前体骨架中引入合适的酶切位点用于外源发夹DNA的克隆,然后将之克隆到含U6启动子的表达载体中。将针对绿色荧光蛋白(greenfluo-rescent protein,GFP)的小干扰RNA克隆到以上表达载体中,通过转染及Western blot来检测新的小干扰RNA表达载体的基因沉默效率。结果:同目前常用的含polIII的小干扰RNA表达载体相比较,用mir30前体骨架表达针对GFP的小干扰RNA的表达载体可以明显抑制GFP的表达。结论:用mir30前体骨架构建的小干扰RNA表达载体可高效表达外源小干扰RNA。 AIM: To construct the vector for efficient expression of siRNA using pre-mir30 backbone. METHODS: By chemical synthesis method, pre-mir30 backbone introduced an appropriate restriction enzyme site for foreign shRNA inserting was cloned into an expressing vector containing U6 promoter. The silencing efficiency of a new siRNA expressing vector was detected by transfection and Western blot. RESULTS: The new vector containing pre-mir30 backbone expressing siRNA against GFP could markedly inhibit the expression of GFP compared with the vector expressing control siRNA. CONCLUSION: siRNA expressing vector constructed by pre-mir30 backbone could highly express foreign siRNA.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2007年第12期1117-1118,1121,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家高技术研究发展计划(863)资助项目(2006AA02Z163)
关键词 小干扰RNA 载体 基因沉默 微小RNA siRNA vector gene silencing microRNA
  • 相关文献

参考文献1

二级参考文献111

  • 1Li Y, Kang J, Friedman J, Tarassishin L, Ye J, Kovalenko A, et al.κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis. Proc Natl Acad Sci USA 1999; 96: 1042-7.
  • 2Stancovski I, Baltimore D. NF-kappaB activation: the I kappaB kinase revealed? Cell 1997; 91: 299-303.
  • 3Baud V, Liu ZG, Bennett B, Suzuki N, Xia Y, Karin M. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev 1999; 13: 1297-308.
  • 4Sun L, Chen ZJ. The novel functions of ubiquitination in signaling.Curr Opin Cell Biol 2004; 16: 339-40.
  • 5Wajant H, Scheurich P. Analogies between Drosophila and mammalian TRAF pathways. Prog Mol Subcell Biol 2004; 34: 47-72.
  • 6Lee FS, Peters RT, Dang LC, Maniatis T. MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta. Proc Natl Acad Sci USA 1998; 95: 9319-24.
  • 7Zhao Q, Lee FS. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta. J Biol Chem 1999; 274:8355-8.
  • 8Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z,Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.Nature 1999; 398: 252-6.
  • 9Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. κB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 1997; 278: 866-9.
  • 10Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G,Croughton K, et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 2004; 6: 97-105.

共引文献5

同被引文献7

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部